1. Introduction {#sec0001}
===============

Essential tremor (ET) is the most common adult movement disorder, causes significant disability, interferes with activities of daily living, and reduces quality of life. For medication-refractory cases, deep brain stimulation (DBS) of the thalamic ventral intermediate nucleus (VIM) is an established, effective, and safe treatment. ([@bib0001]; [@bib0002]; [@bib0003]) However, different groups have suggested that the posterior subthalamic area (PSA), which also incorporates the caudal zona incerta, might be an even more promising stereotactic target. ([@bib0004]; [@bib0005]; [@bib0006]) In a recent prospective, randomized, double-blind crossover trial, our group compared stimulation in the VIM, the traditional DBS target, to stimulation in the PSA. ([@bib0007]) PSA-DBS proved to be more efficient, yielding optimal stimulation effects at lower amplitudes with at least equivalent tremor control, while there was neither a quantitative nor qualitative difference in stimulation induced side effects between the two targets. However, the underlying neuroanatomical correlate remained unexplored.

DBS most likely modulates pathologic activity within the tremor network via cerebello-thalamo-cortical connections, i.e. the dentatorubrothalamic tract (DRTT). ([@bib0008]) Direct targeting of the DRTT has been demonstrated to successfully control tremor ([@bib0009]; [@bib0010]) and effective contacts were located inside or close to the DRTT. ([@bib0008]) However a direct correlation between clinical outcomes and the distance to the DRTT has not yet been proven. ([@bib0008]; [@bib0011]) We hypothesized that the observed differences between PSA and VIM stimulation depend on the proximity of contacts to the DRTT.

2. Methods {#sec0002}
==========

2.1. Study design {#sec0003}
-----------------

Ethics approval (Local vote 12-116), study registration (German Clinical Trials Register No. DRKS00004235), patient selection, implantation procedure and study design have already been described in detail. ([@bib0007]) In brief, 13 patients with medication-refractory ET underwent bilateral stereotactic lead implantation. Landmark-based targeting was used to place leads with one contact on the intercommissural plane and at least one contact below in the PSA and one contact above in the VIM. Three months postoperatively patients entered a randomized, double-blind crossover to evaluate tremor improvement after two months of PSA-DBS and after two months of VIM-DBS. Current-controlled stimulation was used in all patients and stimulation pulse width was always set to 60 µs while frequencies ranged from 130 Hz to 200 Hz.

2.2. Clinical outcome and lead reconstruction {#sec0004}
---------------------------------------------

Tremor Rating Scale (TRS) hemi-scores were obtained at preoperative baseline, after two months of PSA-DBS, and after two months of VIM-DBS. ([@bib0007]) Hemi-scores were calculated as the sum of extremity tremor scores contralateral to stimulation from the TRS parts A + B. For further analysis we calculated the DBS efficiency by dividing the TRS improvement from preoperative baseline by the stimulation amplitude (in mA). DBS leads were identified from postoperative CT scans and lead locations were transformed into the preoperative MRI using the Lead-DBS toolbox ([www.lead-dbs.org](http://www.lead-dbs.org){#interref0001}). ([@bib0012])

2.3. Average DRTT {#sec0005}
-----------------

Since the original study did not include individual diffusion imaging, we created one population-based averaged DRTT per hemisphere from high-quality diffusion imaging data of 32 healthy subjects of the Human Connectome Project (see acknowledgments), which consisted of multi-shell diffusion (bvals = 1000, 3000, 5000; 256 directions) and T1 images. Brain extraction of the b0-images was performed using the BET-tool as implemented in the FMRIB software library (FSL) (FMRIB, Oxford, UK) and distributions of diffusion vectors were estimated for each voxel using BEDPOSTX. ([@bib0013]) The number of fibers per voxel was set to three and diffusion coefficients were modeled using a Gamma distribution. ([@bib0014]) Probabilistic fiber tracking was performed separately for each DRTT with PROBTRACKX2 using modified Euler integration. ([@bib0013]) For all other parameters the respective default settings were used. The contralateral dentate nucleus was chosen as seed region, while the contralateral superior cerebellar peduncle, the ipsilateral red nucleus, and the ipsilateral precentral gyrus served as waypoints. ([@bib0008]; [@bib0009]; [@bib0015]; [@bib0016]) These regions of interest were defined in MNI space (ICBM 2009b NLIN asymmetric) by an experienced neurosurgeon (JW) and transformed to individual diffusion space using the SyN approach implemented in advanced normalization tools (ANTs, <http://stnava.github.io/ANTs/>; ([@bib0017]) MNI to individual T1) and SPM 12 (<http://www.fil.ion.ucl.ac.uk/spm/software/spm12/>; individual T1 to diffusion space). The resulting fiber tracts were visually examined for anatomical accuracy, leading to 62 DRTTs included for further analysis. Each individual track frequency map was transformed into a track probability map according to [@bib0015] and transformed back to MNI space. Finally, probability values per voxel were averaged over all subjects. The course of the population-based average DRTTs was validated in another cohort of nine essential tremor patients with individual diffusion imaging (see supplementary material).

*Distance to average DRTT*

For further analysis, the centers of gravity (COG) of each DRTT were calculated for each transversal slice as$$\begin{pmatrix}
x_{COG} \\
y_{COG} \\
\end{pmatrix} = \frac{\sum_{i = 1}^{n}m_{i}{*\mspace{6mu}}\begin{pmatrix}
x_{i} \\
y_{i} \\
\end{pmatrix}}{\sum_{i = 1}^{n}m_{i}}$$with *x~COG~/y~COG~* representing the coordinates of the COG, and *m~i~* representing the probability value of each voxel *i* with its coordinates *x~i~* and *y~i~* in the respective slice. The resulting coordinates were transformed from MNI space to the DBS patients' individual T1 image via ANTs. Subsequently, the Euclidean distances between the right and left hemispheric VIM and PSA contacts and the closest COG of the respective average DRTT were calculated. The workflow is summarized in [Fig. 1](#fig0001){ref-type="fig"}.Fig. 1WorkflowLegend: Regions of interest (dentate nucleus = green, superior cerebellar peduncle, red nucleus = red, precentral gyrus = yellow) were defined in MNI space in both hemispheres and transformed to the diffusion space of each individual of the human connectome project dataset to perform probabilistic tracking. The resulting individual DRTTs were transformed back to MNI space and averaged to create one DRTT (lilac) per hemisphere. Finally the euclidean distance between each contact (gray dots) and the respective DRTT\'s closest center of gravity (red hotspot) was calculated in the respective patient space. Abbreviations: DRTT = dentatorubrothalamic tract; HCP = Human Connectome Project; ROI = region of interest. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) .Fig 1

2.4. Statistical analysis {#sec0006}
-------------------------

TRS hemi-scores were analyzed with a linear mixed model for repeated measurements to account for the crossover design and multiple measurements per subject and per hemisphere. ([@bib0007]) Differences in distance from the DRTT between PSA and VIM contacts were analyzed using the Wilcoxon signed-rank test. The relationship between distance to the DRTT and stimulation amplitude (in mA) as well as DBS efficiency were analyzed using linear mixed-effect models with the multiple measurements per subject as random-effect. Results are reported as (adjusted) mean values ± standard deviations for the linear mixed model and as median ± interquartile range for the Wilcoxon signed-rank test. *P*-values *p* \< 0.05 were considered statistically significant.

2.5. Data availability {#sec0007}
----------------------

Clinical data, stimulation parameters, lead locations, and averaged DRTTs are available via the Open Science Framework (OSF, dx.doi.org/10.17605/OSF.IO/MU827).

3. Results {#sec0008}
==========

Patient demographics, disease characteristics at baseline, and differences in stimulation parameters have been reported previously. ([@bib0007]) [Fig. 2](#fig0002){ref-type="fig"} illustrates the contact locations in relation to the DRTT. The adjusted means revealed better tremor suppression in the TRS hemi-score under PSA stimulation than under VIM stimulation (*p* = 0.005, PSA: 4.54 (±1.19), VIM: 6.77 (±1.22); [Fig. 3](#fig0003){ref-type="fig"}A). The median distance to the respective DRTT was shorter for PSA contacts (*p* = 0.019, PSA: 2.10 mm (±0.79), VIM: 2.45 mm (±1.11); [Fig. 3](#fig0003){ref-type="fig"}B). Furthermore, the distance to the respective DRTT showed an effect on the stimulation amplitude (*R*² = 0.73; *p* \< 0.001; [Fig. 3](#fig0003){ref-type="fig"}C) and on the efficiency of the stimulation site (*R*² = 0.44; *p* = 0.017; [Fig. 3](#fig0003){ref-type="fig"}D) with shorter distances indicating lower stimulation amplitudes and higher stimulation efficiency.Fig. 2Contact positionsLegend: MNI-transformed contact positions (PSA = red, VIM = blue) in relation to the DRTT. (A) 3D view from anterior with the red nucleus in red, the thalamus in yellow and the averaged DRTT in lilac. ([@bib0018]) (B--E) transversal slices through the T1 MNI template at the different heights indicated in (A). The DRTT is shown as probability map thresholded at 0.5 (see colorbar). Abbreviations: A = anterior; D = dorsal; L = left; DRTT=dentatorubrothalamic tract; PSA = posterior subthalamic area; VIM = ventral intermediate nucleus. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig 2Fig. 3ResultsLegend: Boxplots (median; interquartile interval; range) showing TRS hemi-scores (A) and the distance to the DRTT (B) for PSA and VIM stimulation. PSA stimulation led to lower TRS hemi-scores (*p* = 0.005) and the distance to the DRTT was shorter for PSA contacts (*p* = 0.023). C + D) Relationship between the distance to the DRTT of PSA (light circles) and VIM (dark triangles) contacts and the therapeutic stimulation amplitude (C) as well as the DBS efficiency (D). The shorter the distance to the DRTT, the lower the amplitude (*p*\<0.001) and the higher the efficiency of the respective stimulation (*p* = 0.018) as indicated by the dark line representing the fixed-effect. Abbreviations: DRTT = dentatorubrothalamic tract; PSA = posterior subthalamic area; VIM ventral intermediate nucleus.Fig 3

4. Discussion {#sec0009}
=============

This study demonstrates that the superior efficiency of PSA contacts in comparison to VIM contacts is related to their proximity to the DRTT. Distances to the center of the DRTT were significantly shorter in the PSA and this proximity lead to lower stimulation amplitudes and higher stimulation efficiency. So far, the evidence for a relation between stimulation of the DRTT and tremor improvement remained inconclusive. ([@bib0008]; [@bib0011]) One possible reason might be that the stimulation amplitude has not been considered as a crucial factor. While proximity to the DRTT seems to allow tremor control at low stimulation amplitudes, contacts farther from the DRTT could still achieve similar effects at higher amplitudes. Furthermore, several previous studies suggested that stimulation of the PSA or the caudal zona incerta might lead to at least equivalent ([@bib0007]; [@bib0019]) or even better tremor suppression than VIM-DBS. ([@bib0005]; [@bib0020]) This post-hoc analysis indicates a superiority of the PSA by showing significant differences in TRS hemi-scores while the original results did not show clear PSA superiority for total TRS scores. ([@bib0007]) Taken together, there is still inconclusive evidence regarding the superiority of PSA stimulation. On the other hand, our results show that proximity to the DRTT might be more important than coordinate-based differences and thus coordinate-based categories like PSA vs. VIM stimulation will probably be of less importance with more direct targeting approaches.

The major limitation of this study is that it did not include individual diffusion imaging. On the other hand, population-based ([@bib0021]) or atlas-based ([@bib0022]) DRTTs have been used to investigate DBS effects before. Additionally, the diffusion data used from the human connectome project is superior in quality to most images acquired during clinical routine and while a population-based average tract might neglect individual neuroanatomic aberrations, it might also be less prone to tracking errors which have been shown to occur when identifying individual DRTTs. ([@bib0015]) Most importantly, the average deviation of individual patient DRTTs from our population-based DRTT was within the range of image accuracy (see supplementary material). We employed probabilistic fiber tracking, as it might be better in detecting the DRTT than the deterministic algorithms embedded in commercially-available stereotactic planning software. ([@bib0015]) Additionally, a recent observational case series found similar results using individual diffusion imaging. ([@bib0023])

Even though landmark-based targeting was used when implanting our patients (PSA vs. VIM) ([@bib0007]), the results nonetheless could be explained by proximity to the DRTT. In conclusion, direct targeting of the DRTT, which has been demonstrated to be feasible, could improve outcome even further. ([@bib0009]) Future studies, which prospectively compare direct targeting of the DRTT to landmark-based targeting are needed. Moreover, it should be explored whether visualization of the DRTT can also guide postoperative DBS programming. With population-based averaged tracts this could even be investigated in patients who have not received individual diffusion imaging prior to implantation.
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